Dynamics of IFN-ss responses during respiratory viral infection: insights for therapeutic strategies
Conclusions: In vitro modelling of IFN-β dynamics highlights the potential for intermittent prophylactic doses of exogenous IFN-β to modulate viral infection. This provides important insights to aid the future design of clinical trials of IFN-β in asthma and COPD.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Spalluto, C. M., Watson, A., Mccrae, C., Cellura, D., Burke, H., Cunoosamy, D., Freeman, A., Hicks, A., Hühn, M., Ostridge, K., Staples, K., Vaarala, O., Wilkinson, T. Tags: Respiratory infections Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Clinical Trials | Genetics | Influenza | Respiratory Medicine